This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing metastatic melanoma, and known treatment medication such as Opdualag, a premixed combination of (nivolumab and relatlimab-rmbw) used through intravenous infusions.

Ticker(s): BMY

Who's the expert?

Instituition: Albert Einstein College of Medicine

  • Medical oncologist with extensive experience in treating lung, head and neck, prostate and other types of cancer.
  • Has held clinical and teaching positions at leading cancer centers
  • Clinical expertise is in medical management of lung cancer, head and neck cancer, prostate cancer and is director of the melanoma and sarcoma programs 

Interview Goal
Getting the lay of the land of a known Breast cancer medication

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.